by Spatial omics focuses on mapping the locations and genetic and protein details of thousands of individual cells within tissues to better understand complex multi-cellular interactions at sub-cellular resolution. This developing field leverages technologies like nano-scale laser capture microdissection and multiplexed immunofluorescence to characterize the omics profiles of cells in situ across whole tissue sections and organoids. Advances in probes, reagents, and computational methods now allow proteomics details to be obtained directly from tissue slices or whole slide images with tens of thousands of individual cell addresses simultaneously profiled. The global spatial omics market provides essential tools and services enabling multi-omics cellular profiling at microscopic resolutions directly within intact tissues and organ tissues. This aids in visualizing protein expression patterns, localization of biomarkers, and molecular variations across pathologies at previously impossible scales.
The global Spatial Omics Market is estimated to be valued at US$ 336.5 Bn in 2024 and is expected to exhibit a CAGR of 11% over the forecast period 2024 to 2031, as highlighted in a new report published by Coherent Market Insights.
Market key trends:
One of the major trends in the Global Spatial Omics Market Size is the increased adoption of multiplexing. Earlier spatial techniques could only analyze one or two targets at a time through methods such as RNA in situ hybridization or immunohistochemistry. However, newer techniques can now analyze dozens to hundreds of targets simultaneously through use of combinatorial labeling with fluorescent or chromogenic probes. This enables correlating expression of multiple genes or proteins within the same cell and understanding complex interactions. It has widespread applications from discovering disease biomarkers to elucidating cell type-specific responses. The increased multiplexing is driving more comprehensive spatial analysis at an unprecedented scale.
Porter’s Analysis
Threat of new entrants: The threat of new entrants is moderate. The spatial omics market requires significant investment in R&D which creates entry barriers for new players. However, low brand loyalty allows scope for new players.
Bargaining power of buyers: The bargaining power of buyers is high due to the availability of substitute products. Buyers can switch between providers based on price and quality.
Bargaining power of suppliers: The bargaining power of suppliers is moderate. The presence of many suppliers reduces the individual supplier’s control over pricing. However, suppliers hold some power due to intellectual property rights protection.
Threat of new substitutes: The threat of substitutes is moderate. While there are some alternatives to spatial omics tools, their functionality is limited compared to modern spatial omics solutions.
Competitive rivalry: Competition in the market is high due to the large number of regional and global players. Players compete based on product features, pricing, brand reputation, and customer service.
Key Takeaways
The global Spatial Omics Market is expected to witness high growth.
North America currently dominates the spatial omics market due to presence of major players and availability of research funding. Asia Pacific is expected to witness fastest growth due to increasing R&D investments in countries like China and India.
Key players operating in the spatial omics market are Gilson Company, Inc., Russell Finex Ltd., Retsch GmbH, Lao Soung Machinery Co. Ltd., Endecotts Ltd., Bionics Scientific Technologies Ltd., and Thermo Fischer Scientific. Major players are focusing on new product launches and collaboration to strengthen their product portfolio and market position. For instance, in 2023 Thermo Fischer Scientific launched new Atlas Pro platform for spatial profiling.
*Note:
1. Source: Coherent Market Insights, Public sources, Desk research
2. We have leveraged AI tools to mine information and compile it
